4//SEC Filing
PURE BIOSCIENCE 4
Accession 0001079973-08-000219
$PURECIK 0001006028operating
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:51 PM ET
Size
8.8 KB
Accession
0001079973-08-000219
Insider Transaction Report
Form 4
PURE BIOSCIENCEPURE
Buckland Andrew J
Chief Financial Officer
Transactions
- Award
Common Stock
2008-02-19$0.85/sh+8,334$7,084→ 2,943 total - Sale
Common Stock
2008-02-19$5.53/sh−8,334$46,124→ 2,943 total - Exercise/Conversion
Stock Options
2008-02-19−8,334→ 141,666 totalExercise: $0.85From: 2005-08-02Exp: 2010-08-02→ Common Stock (8,334 underlying)
Footnotes (2)
- [F1]10b5-1 Sale Plan Transactions
- [F2]Incorporates all transactions being reported on this Form 4.
Documents
Issuer
PURE BIOSCIENCE
CIK 0001006028
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001006028
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:51 PM ET
- Size
- 8.8 KB